Beijing Balance Medical Technology Co.,Ltd. (SHA: 688198)
China
· Delayed Price · Currency is CNY 97.82
-0.42 (-0.43%)
Sep 6, 2024, 4:00 PM CST
Beijing Balance Medical Technology Co.,Ltd. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | 106.18 | 115.21 | 95.13 | 51.2 | 56.53 | 63.08 | Upgrade
|
| Depreciation & Amortization | 17.53 | 13.4 | 6.83 | 6.93 | 5.67 | 5.81 | Upgrade
|
| Other Amortization | 1.16 | 0.83 | 0.53 | 0.46 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.06 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | 0 | 0.02 | 0.03 | 0 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | -16.11 | -17.87 | -22.3 | -15.9 | -18.8 | -4.62 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.93 | 1.46 | 1.1 | 0.81 | 1.48 | -0.02 | Upgrade
|
| Other Operating Activities | -11.71 | -5.36 | -0.03 | 0.17 | -0.61 | -0.2 | Upgrade
|
| Change in Accounts Receivable | 50.74 | -30.18 | -22.36 | -30.26 | -26.26 | -0.3 | Upgrade
|
| Change in Inventory | -6.66 | -3.42 | -9.52 | -5.61 | -5.56 | -6.28 | Upgrade
|
| Change in Accounts Payable | -92.2 | 30.82 | 14.34 | 15.96 | 7.18 | 5.88 | Upgrade
|
| Change in Other Net Operating Assets | 16.59 | 29.2 | 58.24 | 80.95 | 34.2 | - | Upgrade
|
| Operating Cash Flow | 62 | 141.17 | 128.85 | 76.49 | 50.76 | 63.88 | Upgrade
|
| Operating Cash Flow Growth | -59.32% | 9.56% | 68.44% | 50.69% | -20.53% | 18.47% | Upgrade
|
| Capital Expenditures | -127.09 | -128.63 | -104.83 | -72.22 | -7.69 | -2.02 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.03 | 0.31 | 0.09 | 0.02 | 0.01 | 0.04 | Upgrade
|
| Cash Acquisitions | -10.84 | -43.28 | - | - | - | - | Upgrade
|
| Investment in Securities | 201.02 | 237.72 | -29.16 | -8.56 | -609 | -3 | Upgrade
|
| Other Investing Activities | 21.03 | 13.18 | 18.88 | 16.13 | 19.74 | 4.44 | Upgrade
|
| Investing Cash Flow | 84.1 | 79.3 | -115.02 | -64.64 | -596.94 | -0.53 | Upgrade
|
| Long-Term Debt Repaid | - | -2.61 | -1.39 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -3.81 | -2.61 | -1.39 | - | - | - | Upgrade
|
| Issuance of Common Stock | 29.34 | 16.9 | 11.34 | 10.78 | - | 519.85 | Upgrade
|
| Common Dividends Paid | -109.26 | -67.84 | -48.22 | -19.2 | -19.2 | - | Upgrade
|
| Other Financing Activities | -1.75 | -0 | -0.04 | -0.87 | -3.54 | -10.34 | Upgrade
|
| Financing Cash Flow | -85.48 | -53.54 | -38.31 | -9.29 | -22.74 | 509.51 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.21 | -0 | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 60.41 | 166.92 | -24.49 | 2.57 | -568.92 | 572.86 | Upgrade
|
| Free Cash Flow | -65.08 | 12.53 | 24.01 | 4.27 | 43.07 | 61.86 | Upgrade
|
| Free Cash Flow Growth | - | -47.80% | 462.20% | -90.08% | -30.38% | 19.58% | Upgrade
|
| Free Cash Flow Margin | -16.53% | 3.38% | 8.14% | 1.70% | 23.68% | 42.36% | Upgrade
|
| Free Cash Flow Per Share | -0.48 | 0.09 | 0.18 | 0.03 | 0.32 | 0.62 | Upgrade
|
| Cash Interest Paid | - | - | 0 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 22.05 | 14.95 | 4.59 | 21.09 | 18.27 | 14.17 | Upgrade
|
| Levered Free Cash Flow | -70.22 | -40.51 | 2.12 | -2.35 | 34.54 | 48.61 | Upgrade
|
| Unlevered Free Cash Flow | -69.89 | -40.25 | 2.17 | -2.28 | 34.54 | 48.61 | Upgrade
|
| Change in Net Working Capital | 32.79 | 17.23 | 3.83 | 30.14 | 24.01 | -2.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.